22 S Greene StBaltimore, MD 21201
Fax+1 410-328-6896
Overview of Dr. Hussain
Dr. Arif Hussain is an oncologist in Baltimore, MD and is affiliated with multiple hospitals in the area, including University of Maryland Medical Center and Veterans Affairs Maryland Health Care System-Baltimore Division. He received his medical degree from Howard University College of Medicine and has been in practice 46 years. Dr. Hussain accepts several types of health insurance, listed below. He is one of 111 doctors at University of Maryland Medical Center and one of 36 doctors at Veterans Affairs Maryland Health Care System-Baltimore Division who specialize in Oncology. He has more than 100 publications and over 500 citings.
Education & Training
University of MarylandFellowship, Hematology and Medical Oncology, 1983 - 1986
MedStar Health Georgetown University/Washington Hospital CenterResidency, Internal Medicine, 1980 - 1983
Howard University College of MedicineClass of 1980
Certifications & Licensure
MD State Medical License 1986 - 2028
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 2 Certification EpicCare Ambulatory EHR Suite, Epic Systems Corporation, 2014-2017
- CMS Meaningful Use Stage 1 Certification EpicCare Ambulatory 2014 Certified EHR Suite, Epic Systems Corporation, 2014-2017
Clinical Trials
- Paclitaxel and Bryostatin 1 in Treating Patients With Metastatic Prostate Cancer
- Hormone Therapy Plus Chemotherapy in Treating Patients With Prostate Cancer
- Zoledronate in Preventing Skeletal (Bone)-Related Events in Men Who Are Receiving Androgen Deprivation Therapy For Prostate Cancer and Bone Metastases
Publications & Presentations
PubMed
- Recruitment strategies in the PROMISE Registry: Evaluating institutional outreach, direct-to-patient marketing, and community engagement approaches in a decentralized ...Channing J Paller, Ken Freitas, Natalie Macario, Christina Tran, Kelly Faville
Contemporary Clinical Trials Communications. 2026-10-01 - 5 citationsPhase I Trial of P-PSMA-101 CAR T Cells in Patients with Metastatic Castration-Resistant Prostate Cancer.Susan F Slovin, Xin Gao, Xiao X Wei, David Y Oh, Rana R McKay
Clinical Cancer Research. 2026-08-14 - Time-restricted eating to entrain circadian rhythms, increase physiological responsiveness, and prevent stressor-induced frailty: A pilot randomized controlled trial.Amber S Kleckner, Carin L Clingan, Shalet James, Odessa Addison, Arif Hussain
Journal of Geriatric Oncology. 2026-08-08
Other
- Chemotherapy in castrate-resistant prostate cancerHussain A, Dawson NA
http://www.uptodate.com/contents/chemotherapy-in-castrate-resistant-prostate-cancer
UpToDate, Wolters Kluwer Health - 2013-01-21
Professional Memberships
- Member
Insurance Accepted
- Aetna Choice POS II
Aetna HMO
Anthem Blue Access PPO
Anthem Blue Preferred HMO
BCBS Blue Card PPO
BCBS California PPO
BCBS Illinois PPO
CareFirst BlueChoice Advantage
CareFirst BlueChoice Network POS
CareFirst BluePreferred PPO
CIGNA HMOCIGNA Open Access
CIGNA PPO
First Health PPO
Great West PPO
HealthAmerica HealthAssurance PPO
Humana ChoiceCare Network PPO
Multiplan PHCS PPO
Multiplan PPO
United Healthcare - Direct Choice Plus POS
United Healthcare - Direct Options PPO - Please verify your coverage with the provider's office directly when scheduling an appointment
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence: